Plexion (sulfacetamide sodium/sulfur)
Acne Antibiotics Topical Pads, Medicated (Ea)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Sulfur is a keratolytic agent and scabicide.
USES: This medication is used to treat several skin problems (acne, acne rosacea, seborrheic dermatitis). Sulfacetamide works by stopping the growth of certain bacteria on the skin that can lead to acne and worsen these other skin conditions. It belongs to a class of drugs known as sulfa antibiotics.
Sulfur works by helping remove the top layer of dead skin. It belongs to a class of drugs known as keratolytics. It may also help kill acne-causing bacteria and unclog pores.
This medication may also contain other ingredients (for example, other keratolytics such as urea).
Generic name: sulfacetamide sodium/sulfur
Pronunciation: (SUL-fa-SEET-a-mide/SUL-fur)
Drug class: Acne Antibiotics
Therapeutic class: Dermatological
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Plexion
Indications
No indications are available for this drug.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
| Drug label | Dosing type | Instructions |
|---|---|---|
| Plexion 9.8-4.8% Clnsing Cloth | Maintenance | Wash the affected area(s) by topical route once daily with cleansing cloth then massage gently 10-20 seconds, rinse, and pat dry. |
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
Severe Interaction: Action is required to reduce the risk of severe adverse interaction.
Topical Sodium Sulfacetamide/Topical Silver
SEVERITY LEVEL: 2-Severe Interaction: Action is required to reduce the risk of severe adverse interaction.
MECHANISM OF ACTION: Topical sodium sulfacetamide and topical silver are physically incompatible.(1,2)
CLINICAL EFFECTS: Concurrent application of topical sodium sulfacetamide and topical silver preparations may result in decreased clinical effectiveness of the products.(1,2)
PREDISPOSING FACTORS: None determined.
PATIENT MANAGEMENT: Avoid using topical silver preparations on the same location as topical sodium sulfacetamide products.(1,2)
DISCUSSION: Topical sodium sulfacetamide and topical silver are physically incompatible.(1,2)
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
- Glucose-6-phosphate dehydrogenase (g6Pd) deficiency
- Hemoglobin H disease
- Hemolytic anemia from pyruvate kinase and g6PD deficiencies
There are no severe contraindications for this drug.
- No disease contraindications
Adverse reactions
There is no enhanced messaging for this drug.
Less Frequent
- Skin irritation
Rare or Very Rare
- Agranulocytosis
- Blood dyscrasias
- Erythema
- Glucose-6-phosphate dehydrogenase (g6Pd) deficiency anemia
- Hepatic necrosis
- Hypersensitivity drug reaction
- Pruritus of skin
- Skin irritation
- Skin rash
- Stevens-johnson syndrome
- Systemic lupus erythematosus
- Toxic epidermal necrolysis
Less Frequent
- Abnormal desquamation
- Erythema
Rare or Very Rare
- Skin inflammation
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.